Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.42 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.42 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.42 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2859138 | 0.86 | CYP2C19 (0.54) | CYP2C9CYP2C19PRMT3CARM1PRMT6 | |
| SCHEMBL2863159 | 0.86 | TDP1 (0.56) | CYP2C9CYP2C19PRMT3CARM1PRMT6 | |
| SCHEMBL11119 | 0.81 | — | — | |
| SCHEMBL344526 | 0.81 | CYP2C9 (0.72) | CYP2C9CYP2C19PRMT3CARM1PRMT6 | |
| SCHEMBL24603130 | 0.79 | KDM4E (0.36) | CYP2C9CYP2C19KDM4ERECQLADRB2 | |
| SCHEMBL18160820 | 0.78 | CYP2C9 (0.50) | CYP2C9CYP2C19PRMT3CARM1PRMT6 | |
| SCHEMBL3631301 | 0.78 | KDM4E (0.42) | CYP2C19KDM4ERECQLADRB2ALDH1A1 | |
| SCHEMBL7790112 | 0.78 | KDM4E (0.42) | CYP2C19KDM4ERECQLADRB2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2532416 | 0.78 | L3MBTL1 (0.43) | TDP1KDM4ERECQLADRB2ALDH1A1 | |
| Iodide SCHEMBL1835511 | 0.78 | KDM4E (0.42) | CYP2C19KDM4ERECQLADRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024232564-A1 | STRONTIUM COMPOUND, METHOD FOR PRODUCING SAME, AND METHOD FOR FORMING THIN FILM USING SAME | 한국화학연구원 | 2024-11-14 | — | — | WO | disclosed |
| US-11655262-B2 | Process for the generation of metal-containing films | BASF SE (DE) | 2023-05-23 | — | — | US | disclosed |
| CN-111727272-B | Method for producing metal-containing films | 巴斯夫欧洲公司 | 2023-04-28 | — | — | CN | disclosed |
| US-20220220131-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | BASF SE (DE) | 2022-07-14 | — | — | US | disclosed |
| US-11319332-B2 | Process for the generation of metal-containing films | BASF SE (DE) | 2022-05-03 | — | — | US | disclosed |
| EP-3957769-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | BASF SE (DE) | 2022-02-23 | — | — | EP | disclosed |
| EP-3728688-B1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | BASF SE (DE) | 2021-11-10 | — | — | EP | disclosed |
| US-20210079520-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | WAYNE STATE UNIVERSITY (US) | 2021-03-18 | — | — | US | disclosed |
| EP-3728688-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | BASF SE (DE) | 2020-10-28 | — | — | EP | disclosed |
| CN-111727272-A | Method for producing metal-containing film | 巴斯夫欧洲公司 | 2020-09-29 | — | — | CN | disclosed |
| US-20090048223-A1 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-20090048223-A1 | Sulfonamide compound | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| CN-101111483-A | IGF-1R inhibitors | KYOWA HAKKO KOGYO KK (JP) | 2008-01-23 | — | — | CN | disclosed |
| EP-1847532-A1 | IGF-1R INHIBITOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-1847532-A1 | IGF-1R INHIBITOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070032532-A1 | Hsp90 family protein inhibitors | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-02-08 | — | — | US | disclosed |
| EP-1642880-A1 | HSP90 FAMILY PROTEIN INHIBITORS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2006-04-05 | — | — | EP | disclosed |
| EP-0134019-B1 | PROCESS FOR THE PREPARATION OF SELF-CURABLE RESINS AND THEIR USE | BASF Lacke + Farben AG (DE) | 1987-07-08 | — | — | EP | disclosed |
| US-4599371-A | CATIONIC POLYMERS FOR ELECTROCOATINGS | BASF AKTIENGESELLSCHAFT (DE) | 1986-07-08 | — | — | US | disclosed |
| EP-0134019-A2 | Process for the preparation of self-curable resins and their use | BASF Lacke + Farben AG (DE) | 1985-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220131-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | NR4A2, NR2C2, NR2E1 | CYP2C9 1756/4885CYP2C19 2016/4885PRMT3 300/4885 |
| US-11655262-B2 | Process for the generation of metal-containing films | NR4A2, NR2C2, NR2E1 | CYP2C9 1756/4885CYP2C19 2016/4885PRMT3 300/4885 |
| US-20070032532-A1 | Hsp90 family protein inhibitors | HSP90AB1, HSP90B1, HSP90AB2P | CYP2C9 1162/4885CYP2C19 1259/4885PRMT3 3196/4885 |
| US-20210079520-A1 | PROCESS FOR THE GENERATION OF METAL-CONTAINING FILMS | NR4A2, NR3C2, NR2C2 | CYP2C9 1947/4885CYP2C19 2351/4885PRMT3 277/4885 |
| US-20090048223-A1 | Sulfonamide compound | ALK, AKT1, ARAF | CYP2C9 1572/4885CYP2C19 1798/4885PRMT3 190/4885 |
| US-11319332-B2 | Process for the generation of metal-containing films | NR4A2, NR2C2, NR2E1 | CYP2C9 1756/4885CYP2C19 2016/4885PRMT3 300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.